Search
for

    Sort by

    Research 91–120 of 1000+

    1. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    2. Editorial comment 1 Urology · 2004
    3. Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo European Urology Supplements · 2003
    4. The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study 2002 · 110 citations
    5. The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study The Aging Male · 2020 · 6 citations
    6. Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention Journal of Clinical Oncology · 2009 · 6 citations
    7. What are the possible reasons for urethral PSA varieties after radical prostatectomy? Acta Chirurgica Iugoslavica · 2010 · 5 citations
    8. Gleason grading controversies: what the chemoprevention trials have taught us Canadian Urological Association Journal · 2013 · 4 citations
    9. Finasteride in Androgenic Alopecia Journal of the Dermatology Nurses’ Association · 2016 · 1 citations
    10. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study. PubMed · 2002 · 1 citations
    11. Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review HORMONES · 2025
    12. Abstract 5561: 20(S)-Protopanaxadiol-aglycone downregulates full-length and ligand-independent splice variants of androgen receptor Cancer Research · 2011
    13. S2 PSA: RELIABLE OR NOT RELIABLE? European Urology Supplements · 2010
    14. S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY European Urology Supplements · 2010
    15. DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP The Journal of Urology · 2009
    16. Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men Cancer Epidemiology and Prevention Biomarkers · 2007
    17. Effect of Low-Dose Finasteride on Serum PSA Concentrations Journal watch · 2007
    18. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    19. Bernstein’s Consent and Information on Finasteride and Propecia® Hair transplant forum international · 2016
    20. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    21. Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice PLOS ONE · 2013 · 9 citations
    22. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    23. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    24. Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial The World Journal of Men s Health · 2023 · 5 citations
    25. Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses Nature Clinical Practice Urology · 2007
    26. 1465 骨材がコンクリートの乾燥収縮ひずみに及ぼす影響 : その1. 実験計画および実験結果(収縮・クリープ(5),材料施工) 学術講演梗概集. A-1, 材料施工 · 2010
    27. A Review on the Clinical Utility of PSA in Cancer Prostate Indian Journal of Surgical Oncology · 2012 · 154 citations
    28. Faculty Opinions recommendation of Screening for prostate cancer. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
    29. How not to detect prostate cancer Lancet Oncology · 2007
    30. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations